v3.26.1
Revenue (Tables)
 12 Months Ended
Apr. 24, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Net Sales by Segment and Division and by Market Geography
The table below includes net sales by geography for the fiscal years ended April 24, 2026, April 25, 2025, and April 26, 2024:
Fiscal Year
(in millions)202620252024
U.S.(1)
$917 $903 $833 
International(2)
2,185 1,812 1,636 
Total$3,102 $2,715 $2,469 
(1)U.S. includes the United States and U.S. territories.
(2)International includes all other non-U.S. countries.

The table below includes net sales by product category for the fiscal years ended April 24, 2026, April 25, 2025, and April 26, 2024:
Fiscal Year
(in millions)202620252024
Pumps$546 $541 $540 
Consumables956 854 777 
CGM1,553 1,313 1,117 
Other (1)
46 6 34 
Total$3,102 $2,715 $2,469 
(1) Primarily includes revenue generated from the sale of smart insulin pens and services. Amounts in this line also reflect adjustments to the Company's Italian payback accruals resulting from two rulings in 2024 by the Constitutional Court of Italy and the Legislative Decree published by the Italian government on June 30, 2025 for certain prior years since 2015. Refer to Note 12. “Commitments and Contingencies,” for more information.
Fiscal Year
(in millions)202620252024
Pumps$546 $541 $540 
Consumables956 854 777 
CGM1,553 1,313 1,117 
Other (1)
46 6 34 
Total$3,102 $2,715 $2,469 

(1) Primarily includes revenue generated from the sale of smart insulin pens and services. Amounts in this line also reflect adjustments to the Company's Italian payback accruals resulting from two rulings in 2024 by the Constitutional Court of Italy and the Legislative Decree published by the Italian government on June 30, 2025 for certain prior years since 2015. Refer to Note 12. “Commitments and Contingencies,” for more information.